Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Phillips

Showing results (701-710 of 1,132) with videos related to

Pageof 114
Sort By:
The Journal of Biological Chemistry|August 21, 2008
Structure of human J-type co-chaperone HscB reveals a tetracysteine metal-binding domainEduard Bitto, Craig A Bingman, Lenka Bittova, et al.
Antiviral Therapy|January 30, 2003
Analysis of virological efficacy in trials of antiretroviral regimens: drawbacks of not including viral load measurements after premature discontinuation of therapyOle Kirk, Court Pedersen, Matthew Law, et al.
American Journal of Respiratory and Critical Care Medicine|September 16, 2000
Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JDO Kirk, J M Gatell, A Mocroft, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 21, 2004
Use of viral load measured after 4 weeks of highly active antiretroviral therapy to predict virologic outcome at 24 weeks for HIV-1-positive individualsColette J Smith, Schlomo Staszewski, Caroline A Sabin, et al.
The American Journal of Gastroenterology|June 30, 2005
Decline in esophageal candidiasis and use of antimycotics in European patients with HIVAmanda Mocroft, Cristina Oancea, Jan van Lunzen, et al.
AIDS (London, England)|May 24, 2013
CD4 cell count and viral load-specific rates of AIDS, non-AIDS and deaths according to current antiretroviral useAmanda Mocroft, Andrew N Phillips, Jose Gatell, et al.
Msphere|November 21, 2017
<i>Pseudomonas aeruginosa</i> Contact-Dependent Growth Inhibition Plays Dual Role in Host-Pathogen InteractionsJeffrey A Melvin, Jordan R Gaston, Shawn N Phillips, et al.
HIV Medicine|May 16, 2002
The changing demographics of new HIV diagnoses at a London centre from 1994 to 2000S M Barry, S J Lloyd-Owen, S J Madge, et al.
Journal of Molecular Biology|February 27, 2007
Structure and interactions of the first three RNA recognition motifs of splicing factor prp24Euiyoung Bae, Nicholas J Reiter, Craig A Bingman, et al.
Lancet (London, England)|July 31, 2007
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort studyA Mocroft, A N Phillips, J Gatell, et al.
Pageof 114

Showing results (701-710 of 1,132) with videos related to

Sort By:
Pageof 114
The Journal of Biological Chemistry|August 21, 2008
Structure of human J-type co-chaperone HscB reveals a tetracysteine metal-binding domainEduard Bitto, Craig A Bingman, Lenka Bittova, et al.
Antiviral Therapy|January 30, 2003
Analysis of virological efficacy in trials of antiretroviral regimens: drawbacks of not including viral load measurements after premature discontinuation of therapyOle Kirk, Court Pedersen, Matthew Law, et al.
American Journal of Respiratory and Critical Care Medicine|September 16, 2000
Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JDO Kirk, J M Gatell, A Mocroft, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 21, 2004
Use of viral load measured after 4 weeks of highly active antiretroviral therapy to predict virologic outcome at 24 weeks for HIV-1-positive individualsColette J Smith, Schlomo Staszewski, Caroline A Sabin, et al.
The American Journal of Gastroenterology|June 30, 2005
Decline in esophageal candidiasis and use of antimycotics in European patients with HIVAmanda Mocroft, Cristina Oancea, Jan van Lunzen, et al.
AIDS (London, England)|May 24, 2013
CD4 cell count and viral load-specific rates of AIDS, non-AIDS and deaths according to current antiretroviral useAmanda Mocroft, Andrew N Phillips, Jose Gatell, et al.
Msphere|November 21, 2017
<i>Pseudomonas aeruginosa</i> Contact-Dependent Growth Inhibition Plays Dual Role in Host-Pathogen InteractionsJeffrey A Melvin, Jordan R Gaston, Shawn N Phillips, et al.
HIV Medicine|May 16, 2002
The changing demographics of new HIV diagnoses at a London centre from 1994 to 2000S M Barry, S J Lloyd-Owen, S J Madge, et al.
Journal of Molecular Biology|February 27, 2007
Structure and interactions of the first three RNA recognition motifs of splicing factor prp24Euiyoung Bae, Nicholas J Reiter, Craig A Bingman, et al.
Lancet (London, England)|July 31, 2007
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort studyA Mocroft, A N Phillips, J Gatell, et al.
Pageof 114